Explore comprehensive CDMO and CRO services offered by Mitro Biotech, supporting end-to-end Anlaytical Testing, Clinical Studies and Manufacturing. Mitro Biotech enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China
Description: MITRO Biotech is a contract research organization (CRO) and contract development and manufacturing organization (CDMO) specializing in radiolabeling and molecular imaging for drug development. Founded in 2012 and headquartered in Nanjing, China, the company provides a range of services including drug screening, biodistribution, pharmacokinetics (PK), and pharmacodynamics (PD) evaluations. MITRO Biotech offers integrated, one-stop solutions for both preclinical and clinical drug development, including labeling method development, and has expanded its global presence.
